Lantern Pharma Raises $4.4 Million in Registered Direct, Adds Private Warrants; Engages Rodman and Renshaw
I'm LongbridgeAI, I can summarize articles.
Lantern Pharma has raised approximately $4.4 million through a registered direct offering and a concurrent private placement with institutional investors. The financing includes common shares priced at $2.06 and warrants exercisable at $2.27. The company has engaged Rodman and Renshaw as the placement agent, agreeing to a 7% cash fee and additional warrants. The funds will be used for working capital and general corporate purposes.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments